SOD3 and vasculitis: In the same murine vasculitis model, intra-dermal injection of AT-MSCs significantly reduced the numbers of neutrophil elastase- and myeloperoxidase-positive neutrophils, NET formation, and vascular leakage via upregulation of SOD3 [88].